Sutro Biopharma

Sutro is a biopharmaceutical firm that develops novel protein and multi-specific antibody-based therapeutics for the treatment of cancer.

Business Model:

Revenue: $69.8M

Employees: 201-500

Detailed Sutro Biopharma Information

Geographic Data

Sutro Biopharma headquarters map

Address: 111 Oyster Point Blvd

City: South San Francisco

State: CA

Zip: 94080

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$145M

Raised Total:

$347M

Metrics

3,082,186Website Global Rank

5,491Website Monthly Traffic

Twitter Followers

Description

Sutro is a biopharmaceutical firm that develops novel protein and multi-specific antibody-based therapeutics for the treatment of cancer.

Contact Phone:
+16503928412

Contact Email:

Sutro Biopharma went public on 9/26/2018 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
9/26/2018

IPO Valuation:
$342M

Ticker Symbol:
STRO

IPO Price:
$15/share

Amount Raised:
$85M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
10/2007 Venture Round $0 International Biotechnology Trust
SV Health Investors
International Biotechnology Trust
SV Health Investors
3/2009 Series B 2 $15M Alta Partners
SV Health Investors
Alta Partners
SV Health Investors
9/2018 IPO $85M
12/2007 Series B 2 $21M SV Health Investors
Alta Partners
SV Health Investors
12/2013 Series D $0 Skyline Ventures
SV Health Investors
Eli Lilly
Celgene
Amgen Ventures
Alta Partners
Skyline Ventures
SV Health Investors
Eli Lilly
Celgene
Amgen Ventures
Alta Partners
5/2018 Series E $85.4M Samsara BioCapital
Alta Partners
Amgen Ventures
Celgene Corporation
Lilly Ventures
Skyline Ventures
SV Health Investors
Nexthera Capital
Vida Ventures
1/2006 Series A 1 $1M SV Health Investors
12/2020 Post-IPO Equity 1 $144.9M Frazier Healthcare Partners
Frazier Healthcare Partners
5/2012 Series C 5 $16.5M SV Health Investors
Skyline Ventures
Lilly Ventures
Amgen Ventures
Alta Partners
7/2018 Series E $0 Citadel
Vida Ventures
Samsara BioCapital
Merck
Skyline Ventures
Lilly Ventures
Centene
Celgene
SV Health Investors
Nexthera Capital
Samsara BioCapital
Surveyor Capital
Alta Partners
Amgen Ventures
Eventide
Tekla Capital Management
Citadel
Vida Ventures
Samsara BioCapital
Merck
Skyline Ventures
Lilly Ventures
Centene
Celgene
SV Health Investors
Nexthera Capital
Samsara BioCapital
Surveyor Capital
Alta Partners
Amgen Ventures
Eventide
Tekla Capital Management
11/2010 Series C 5 $36.5M Skyline Ventures
SV Health Investors
Lilly Ventures
Amgen Ventures
Alta Partners
Skyline Ventures
12/2013 Series D 6 $26M Alta Partners
Skyline Ventures
SV Life Sciences
7/2018 Series E 15 $85.4M Vida Ventures
Samsara BioCapital
Merck Sharp &a; Dohme Sweden AB
Skyline Ventures
Lilly Ventures
Centene
Celgene
SV Health Investors
Nexthera Capital
Samsara BioCapital
Surveyor Capital
Vida Ventures
Samsara BioCapital
Merck Sharp &a; Dohme Sweden AB
Skyline Ventures
Lilly Ventures
Centene
Celgene
SV Health Investors
Nexthera Capital
Samsara BioCapital
Surveyor Capital
10/2007 Venture Round 2 $305k
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research